Pfizer, Rambus, and Pepsi Moves

Kim Kahn summarizes Pfizer's outlook, Rambus supply constraints, and PepsiCo's dividend hike and $10B buyback.

Play episode from 01:56

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!